Distinguished Cardiac Researcher Elected to Association of University Cardiologists
Nanette H. Bishopric, M.D., professor of medicine, pediatrics and pharmacology and Director of the UM Cardiovascular Genomics Laboratory, has been elected to the prestigious Association of University Cardiologists. Founded in 1961, the Association is limited to an active membership of 125 academic cardiologists who are selected for pioneering the course of research and training in cardiovascular disease in the United States.
“This is a tremendous honor and milestone achievement for an academic cardiologist,” Bishopric said. “It is a privilege to be in the company of so many highly successful and distinguished clinician leaders.”
As part of her membership, at the Association’s 53rd annual scientific meeting January 8-10 in Phoenix, Bishopric presented “Inhibitors and Effectors of Hypertrophy at the EP300 Node,” which reviewed her pioneering work on molecular mechanisms of heart growth and failure.
Bishopric joins only three other Miller School faculty members in the exclusive association: Pascal J. Goldschmidt, M.D., Senior Vice President for Medical Affairs and Dean of the Miller School and CEO of UHealth, Joshua M. Hare, M.D., the Louis Lemberg Professor of Medicine, founding Director of the Interdisciplinary Stem Cell Institute and Chief Science Officer at the Miller School, and Robert J. Myerburg, M.D., professor of medicine and physiology.
“The AUC has a numerical limit on membership, and election to the organization attests to the candidate’s standing in the field of academic cardiology,” said Myerburg, who sponsored Bishopric’s application. “It is based on the strength and volume of the candidate’s scientific and/or clinical contributions to the field. Dr. Bishopric was elected into the organization on her first nomination.”
A prolific physician and researcher who joined the Miller School in 1996, Bishopric has made major contributions to the field of cardiovascular disease. Her seminal findings have uncovered pathways for inhibiting cardiac hypertrophy, shedding light on the regulation of heart growth; improved knowledge of the role of cardiac apoptosis in understanding the pathogenesis of heart failure; revealed a predictor of stem cell efficacy in treating heart failure; and advanced medical understanding of the role of genetics in patients with torsades de pointes, a deadly heart arrhythmia.
In addition to being a fellow of the American College of Cardiology and American Heart Association, Bishopric is a member of the American Clinical and Climatological Association. She also received the “Stop Heart Disease” Researcher of the Year Award from the Florida Heart Research Institute in 2005, and in 2010 earned the Distinguished Scientist Award, one of the most prestigious awards presented by the American College of Cardiology.